Market Tracker

12/09 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

2.50
Delayed Data
As of 4:00pm ET
 -0.10 / -3.85%
Today’s Change
2.13
Today|||52-Week Range
10.18
-71.33%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close2.60
Today’s open2.60
Day’s range2.35 - 2.70
Volume699,232
Average volume (3 months)413,970
Market cap$137.6M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-40.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
AKAOAchaogen Inc+0.22+4.37%
ATHXAthersys Inc+0.01+0.63%
XENEXenon Pharmaceutical...+0.20+2.56%
CTICCTi Biopharma Corp+0.01+1.17%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts